JPMorgan’s Sharp Reversal… And The Latest Entry To The Weight Loss Drug Battle 5/20/24
Shares of JPMorgan losing steam in the session after CEO Jamie Dimon’s comments on owning the bank, and his own succession plans. Where the financial heavyweight is heading next. Plus Telehealth provider Hims & Hers surging after announcing it will offer GLP-1 injections. How they’re hoping to tip the scales in the obesity drug wars.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
2024-05-20
43 min
Available Results
Generated results are saved to the knowledge database for reuse and search.
No generated results are available for this episode yet.
Extract Knowledge
Pick what you want extracted first. Model, scope, and chapter options appear after a template is selected.
Generated results for public episodes are saved to the knowledge database so they can be reused and searched later.
Transcript
No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in
Chapters
No chapters available.